Press Releases - 2023-05-03

Date	Title	Company
03-May-2023	Apertura Gene Therapy Announces Scientific Founder Presentations on AAV Capsid Engineering Platforms at ASGCT 2023 Annual Meeting	Businesswire
03-May-2023	Antiviral Drugs Market Would Rocket Up to at a Value of USD 85,392.59 million by 2030	The Wire Times
03-May-2023	Odyssey Investment Partners Portfolio Company Applied Technical Services Expands Market-Leading Client Service Offerings Through Continued M&A Activity	Businesswire
03-May-2023	Marinus Pharmaceuticals to Present at Upcoming Investor Conferences	Businesswire
03-May-2023	GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023	Businesswire
03-May-2023	Newron to Present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)	Businesswire
03-May-2023	Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results	Businesswire
03-May-2023	Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results	Businesswire
03-May-2023	Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy	Businesswire
03-May-2023	2 Day Training Course on Advanced Regulatory Affairs for Medical Devices: October 9-10, 2023 - ResearchAndMarkets.com	Businesswire
03-May-2023	CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor	CluePoints
03-May-2023	AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs	AARDEX Group
03-May-2023	Merck to Participate in Bank of America Securities 2023 Healthcare Conference	Businesswire
03-May-2023	Laboratory Information Management Systems (LIMS) Market Trends, Share, Industry Size, Growth, Demand, Opportunities and Global Forecast By 2029	The Wire Times
03-May-2023	ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer Results Show Statistically Significant Improvements in PFS, ORR, and OS Compared to Chemotherapy First Medicine to Demonstrate an Overall Survival Advantage in Platinum-Resistant Ovarian Cancer Submission of MAA in Europe and sBLA in US Anticipated in H2 2023	ImmunoGen Inc.
03-May-2023	Bloomsbury Genetic Therapies Receives Rare Paediatric Disease Designation from the U.S. FDA for BGT-DTDS for the Treatment of Dopamine Transporter Deficiency Syndrome (DTDS)	Bloomsbury Genetic Therapies Limited
03-May-2023	Otsuka announces NICE recommendation of Lupkynis® (voclosporin) with mycophenolate mofetil for treating active lupus nephritis	Otsuka Pharmaceuticals (U.K.) Ltd.
03-May-2023	Phesi publishes first edition of Digital Patient Profile Catalog to enable adoption of Digital Twins and improve patient centricity in drug development	Phesi
03-May-2023	Meditation Market Share, Size, Worth USD 20,532.44 Million at a CAGR of 18.5% During the Forecast Period 2029	The Wire Times
03-May-2023	Membrane Microfiltration Global Market Report 2023: Increased Environmental Concern and Strict Legislation on Wastewater Treatment Fuels Growth - ResearchAndMarkets.com	Businesswire